Production (Stage)
Fulcrum Therapeutics, Inc.
FULC
$6.85
$0.071.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 226.60M | 241.02M | 257.23M | 273.78M | 213.31M |
| Total Receivables | 2.54M | 3.34M | 5.23M | 3.53M | 1.08M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.41M | 5.56M | 5.03M | 2.97M | 3.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 232.56M | 249.92M | 267.49M | 280.29M | 217.95M |
|
|
|||||
| Total Current Assets | 232.56M | 249.92M | 267.49M | 280.29M | 217.95M |
| Net Property, Plant & Equipment | 8.88M | 9.58M | 10.24M | 10.77M | 11.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.21M | 1.21M | 1.28M | 3.21M | 3.19M |
| Total Assets | 242.65M | 260.72M | 279.01M | 294.26M | 232.59M |
|
|
|||||
| Total Accounts Payable | 1.51M | 1.16M | 4.04M | 3.58M | 3.86M |
| Total Accrued Expenses | 3.91M | 7.23M | 7.93M | 6.73M | 4.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.24M | 2.19M | 2.13M | 2.08M | 2.03M |
| Total Finance Division Other Current Liabilities | 441.00K | 463.00K | 400.00K | 306.00K | 385.00K |
| Total Other Current Liabilities | 441.00K | 463.00K | 400.00K | 306.00K | 385.00K |
| Total Current Liabilities | 8.10M | 11.04M | 14.51M | 12.70M | 10.69M |
|
|
|||||
| Total Current Liabilities | 8.10M | 11.04M | 14.51M | 12.70M | 10.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.87M | 6.44M | 7.01M | 7.57M | 8.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 197.00K | 197.00K | 197.00K | 197.00K | 197.00K |
| Total Liabilities | 14.16M | 17.68M | 21.72M | 20.47M | 19.00M |
|
|
|||||
| Common Stock & APIC | 765.47M | 762.30M | 759.74M | 755.29M | 750.57M |
| Retained Earnings | -537.05M | -519.40M | -502.83M | -481.13M | -536.54M |
| Treasury Stock & Other | 70.00K | 130.00K | 379.00K | -366.00K | -434.00K |
| Total Common Equity | 228.49M | 243.03M | 257.29M | 273.79M | 213.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 228.49M | 243.03M | 257.29M | 273.79M | 213.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 228.49M | 243.03M | 257.29M | 273.79M | 213.59M |
|
|
|||||